These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 5388724)
61. Complications following oral administration of exchange resins in extremely low-birth-weight infants. Ohlsson A; Hosking M Eur J Pediatr; 1987 Nov; 146(6):571-4. PubMed ID: 3428292 [TBL] [Abstract][Full Text] [Related]
62. Sodium Polystyrene Sulfonate in Sorbitol-Induced Colonic Ulcerations. Bansal R; Abdu A; Arya V Am J Gastroenterol; 2018 Jan; 113(1):11. PubMed ID: 29311732 [No Abstract] [Full Text] [Related]
63. [Hemosorbtion as a method of body disintoxication]. Lopukhin IuM; Molodenkov MN; Shuralin BK; Kuznetsov VN; Nalivaĭko ES Khirurgiia (Mosk); 1977 Jan; (1):18-20. PubMed ID: 846111 [No Abstract] [Full Text] [Related]
64. Resin hemoperfusion in the treatment of drug intoxication. Rosenbaum JL; Winsten S; Kramuer MS; Moros J; Raja R Trans Am Soc Artif Intern Organs; 1970; 16():134-40. PubMed ID: 5454158 [No Abstract] [Full Text] [Related]
65. Asymptomatic Cecal Perforation in a Renal Transplant Recipient After Sodium Polystyrene Sulfonate Administration. Singla M; Shikha D; Lee S; Baumstein D; Chaudhari A; Carbajal R Am J Ther; 2016; 23(4):e1102-4. PubMed ID: 25415544 [TBL] [Abstract][Full Text] [Related]
66. Approach to hyperkalemia. Lim S Acta Med Indones; 2007; 39(2):99-103. PubMed ID: 17933080 [TBL] [Abstract][Full Text] [Related]
67. [Calcium-resonium]. Lackenschweiger A; Weissel W Wien Z Inn Med; 1968; 49(6):216-8. PubMed ID: 5737580 [No Abstract] [Full Text] [Related]
68. Risks and Benefits of Sodium Polystyrene Sulfonate for Hyperkalemia in Patients on Maintenance Hemodialysis. Nakamura T; Fujisaki T; Miyazono M; Yoshihara M; Jinnouchi H; Fukunari K; Awanami Y; Ikeda Y; Hashimoto K; Yamasaki M; Nonaka Y; Fukuda M; Kishi T; Ikeda Y Drugs R D; 2018 Sep; 18(3):231-235. PubMed ID: 30097847 [TBL] [Abstract][Full Text] [Related]
69. Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients. Mahajan SK; Mangla M; Kishore K J Assoc Physicians India; 2001 Nov; 49():1082-5. PubMed ID: 11868861 [TBL] [Abstract][Full Text] [Related]
70. [Treatment using polystyrolsulfonic resin in the calcic stage of hyperkalemia in subjects with chronic uremia receiving and not receiving a periodic hemodialysis treatment]. Sorice PS; Esposito E; Tufano L; Dell'Aversano MR Minerva Nefrol; 1971; 18(6):302-8. PubMed ID: 5173641 [No Abstract] [Full Text] [Related]
71. [What is your diagnosis? Hyperkalemia in acute kidney failure in known chronic kidney failure]. Sieber U; Escher R; Wallmann D Praxis (Bern 1994); 2009 Oct; 98(21):1195-7. PubMed ID: 19844877 [No Abstract] [Full Text] [Related]
72. Efficacy of the cation exchange resin, sodium polystyrene sulfonate, to decrease iron absorption. Shepherd G; Klein-Schwartz W; Burstein AH J Toxicol Clin Toxicol; 2000; 38(4):389-94. PubMed ID: 10930055 [TBL] [Abstract][Full Text] [Related]
73. [Cation exchange resins in therapy]. PENATI F; CASTELLANO M; SGARBI M Minerva Med; 1954 Jul; 45(53):1-13. PubMed ID: 13203220 [No Abstract] [Full Text] [Related]
74. Treatment of hyperkalemia with a calcium-resin. Berlyne GM; Janabi K; Shaw AB; Hocken AG Lancet; 1966 Jan; 1(7430):169-72. PubMed ID: 4164888 [No Abstract] [Full Text] [Related]
75. Disorders of potassium metabolism. Katsikas JL; Goldsmith C Med Clin North Am; 1971 Mar; 55(2):503-12. PubMed ID: 4926064 [No Abstract] [Full Text] [Related]
76. Use of sodium polystyrene sulfonate in sorbitol in the United States, 1985-1989. Gerstman BB; Platt R Am J Kidney Dis; 1991 Nov; 18(5):619-20. PubMed ID: 1951347 [No Abstract] [Full Text] [Related]
77. Treatment of hyperkalemia in acute renal failure using exchange resins. KNOWLES HC; KAPLAN SA AMA Arch Intern Med; 1953 Aug; 92(2):189-94. PubMed ID: 13079339 [No Abstract] [Full Text] [Related]
78. Complications of uremia. Hull AR Urol Clin North Am; 1982 Jun; 9(2):275-8. PubMed ID: 6285576 [No Abstract] [Full Text] [Related]
79. [Letter: Management of hyperkalemia during necessary spironolactone administration]. Lohmann FW Dtsch Med Wochenschr; 1976 Jun; 101(25):975. PubMed ID: 1278018 [No Abstract] [Full Text] [Related]
80. Treatment of hypercalcemia and hyperkalemia. Coniglione TC Med Times; 1978 Jul; 106(7):69-75. PubMed ID: 672557 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]